ArticleProbiotics and antimicrobial proteins2026
Probiotic Characterization of a Novel Enterococcus faecium CPU2401 from Pickles: Unraveling Genomic Mechanisms Underlying the Combating of Oxidative Stress and Infection.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Enterococcus faecium CPU2401, isolated from traditional pickles, was assessed for its probiotic potential through an integrated approach combining whole-genome sequencing and phenotypic assays. The complete genome (2,803,294 bp) comprises a chromosome (2,724,439 bp) and a plasmid (78,855 bp), with a GC content of 38.38% and 2,786 predicted genes. Genomic analysis revealed the presence of various resistance genes (e.g., optrA, efmA) and numerous genes involved in secondary metabolite synthesis, such as carbohydrate-active enzymes (CAZymes). Phenotypically, E. faecium CPU2401 exhibited high gastrointestinal tolerance, with survival rates of 55.4% at pH 4 and 86.7% in the presence of 0.1% bile salts. It also showed good antioxidant capacity, scavenging 3.83% of DPPH, 22.0% of hydroxyl, and 83.4% of superoxide anion radicals, together with notable antibacterial activity against pathogens including Salmonella Typhimurium and Staphylococcus aureus. In Caenorhabditis elegans, E. faecium CPU2401 enhanced resistance to S. Typhimurium infection and significantly extended lifespan by 22.4% compared to the control. These findings underscore the strain's promise as a probiotic candidate for functional food and health applications.
Indexed as
Identifiers
41790426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.